Zhixin Liao

Zhixin Liao


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
GYGui-Yang Yao
Gui-Yang Yao
MYMan-Yi Ye
Man-Yi Ye
RHRi-Zhen Huang
Ri-Zhen Huang
YLYa-Jun Li
Ya-Jun Li
YPYing-Ming Pan
Ying-Ming Pan
HWHeng-Shan Wang
Heng-Shan Wang

3 June 2016 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
LWLing Wu
Ling Wu
ZLZhixin Liao
Zhixin Liao
CLChao Liu
Chao Liu
HJHaiyang Jia
Haiyang Jia
JSJinyue Sun
Jinyue Sun

1 December 2024 in Food & Medicine Homology
Verified
Journal Article
Open access
PDF file
JWJin Wang
Jin Wang
ZLZhixin Liao
Zhixin Liao
With its cellular/subcellular size, microrobots expand a new vision for exploring drug delivery. It has unique advantages in achieving targeted delivery and precise recruitment of chemotherapy drugs. This paper reviews the relevant research at home and abroad in recent years. It searches the relevant literature in the past 10 years with the keywords “tumor drugs” and “micro-nano robots”. The results obtained were described according to “research progress of tumor therapeutic drugs”, “nano drug delivery system” and “microrobots drug delivery”. Then focused the main discussion on “microrobots and cancer drug delivery”. Through this research, its micro-size and multi-source drive provides microrobots technical basis. As the result, they can achieve in-vivo motion efficiency, targeted path planning, biological barrier penetration and efficient drug delivery. It might be beneficial for microrobots to earn better therapeutic of tumor drugs, while decreasing side-effects to other tissues and organs in the future.

6 November 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SZShifeng Zhao
Shifeng Zhao
YHYuan He
Yuan He
CWChungu Wang
Chungu Wang
IAIsraa Assani
Israa Assani
PHPeilei Hou
Peilei Hou
SSSongdong Shen
Songdong Shen
Four new purified polysaccharides (PAP) were isolated and purified from the Enteromorpha prolifera by alkali extraction, and further characterization was investigated. Their average molecular weights of PAP-1, PAP-2, PAP-3, and PAP-4 were estimated as 3.44 × 104, 6.42 × 104, 1.20 × 105, and 4.82 × 104 Da, respectively. The results from monosaccharide analysis indicated that PAP-1, PAP-2, PAP-3 were acidic polysaccharides and PAP-4 was a neutral polysaccharide. PAP-1 and PAP-2 mainly consist of galacturonic acid, while PAP-3 and PAP-4 mainly contained rhamnose. Congo red test showed that no triple helical structure was detected in the four polysaccharides. The antioxidant activities were investigated using 1,1-diphenyl-2-picrylhydrazyl (DPPH), Superoxide, and 2, 2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical assay. In vitro antitumor activities were evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. PAP-1 exhibited relatively stronger antioxidant activities among the four polysaccharides in a dose-dependent manner. At a concentration of 1.00 mg/mL, the antioxidant activities of PAP-1 on the DPPH radical scavenging rate, superoxide anion radical scavenging rate, and ABTS radical rate at 1.00 mg/mL were 56.40%, 54.27%, and 42.07%, respectively. They also showed no significant inhibitory activity against MGC-803, HepG2, T24, and Bel-7402 cells. These investigations of polysaccharides provide a scientific basis for the use of E. prolifera as an ingredient in functional foods and medicines.

1 March 2019 in MedChemComm
Verified
Journal Article
Closed access
PDF file
RHRi-Zhen Huang
Ri-Zhen Huang
GLGui-Bin Liang
Gui-Bin Liang
MLMei-Shan Li
Mei-Shan Li
YFYi-Lin Fang
Yi-Lin Fang
SZShi-Feng Zhao
Shi-Feng Zhao
HWHeng-Shan Wang
Heng-Shan Wang
A series of asiatic acid (AA) based 1,2,3-triazole derivatives were designed, synthesized and subjected to a cell-based NF-κB inhibition screening assay. Among the tested compounds, compound 6k displayed impressive NF-κB inhibitory activity with an IC50 value in the low micromolar range. A molecular docking study was performed to reveal key interactions between 6k and NF-κB in which the 1,2,3-triazole moiety and the hydroxyl groups of the AA skeleton were important for improving the inhibitory activity. Subsequently, surface plasmon resonance analysis validated the high affinity between compound 6k and NF-κB protein with an equilibrium dissociation constant (KD) value of 0.36 μM. Further studies showed that compound 6k observably inhibited the NF-κB DNA binding, nuclear translocation and IκBα phosphorylation. Moreover, in vitro antitumor activity screening showed that compound 6k (IC50 = 2.67 ± 0.06 μM) exhibited the best anticancer activity against A549 cells, at least partly, by inhibition of the activity of NF-κB. Additionally, the treatment of A549 cells with compound 6k resulted in apoptosis induction potency and in vitro cell migration inhibition. Thus, we conclude that AA based 1,2,3-triazole derivatives may be potential NF-κB inhibitors with the ability to induce apoptosis and suppress cell migration.

1 September 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RHRi-Zhen Huang
Ri-Zhen Huang
GLGui-Bin Liang
Gui-Bin Liang
XHXiao-Chao Huang
Xiao-Chao Huang
BZBin Zhang
Bin Zhang
MZMei-Mei Zhou
Mei-Mei Zhou
HWHeng-Shan Wang
Heng-Shan Wang